Genomic Vision announced that it has joined France BioLead. The France BioLead Association was officially launched in December 2022 by the French government and 15 founding members, players from all the biomanufacturing value chains. Its mission is to structure, steer, support, animated and promote the French biomanufacturing industry and its players.

Its purpose is to support the development of the various technological value chains of a sovereign and innovative French biomanufacturing industry throughout the life cycle of the biomedical product, to ensure the availability of biomedical products for patients, and to build an attractive and recognized industry, particularly internationally. Its three major objectives for 2030 are: to double the proportion of biomedical products produced in France, to double the number of jobs in the sector (from 10,000 to 20,000), and to enable the emergence of at least one new unicorn and five new biotech SMEs. As part of its membership, Genomic Vision will have access to France BioLead's network of experts and industry leaders, as well as opportunities to participate in a range of events and initiatives, including industry conferences and seminars.